|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukemia and myelodysplastic syndromes显示文摘 | Verstovsek S Estey E Manshouri T | 2002 | Br J Haematol2002，118，1： | 1 |
| 2 | Diagnosis and management of acute myeloid leukemia in adults:recommendations from an international expert panel,on behalf of the European Leukemia Net显示文摘 | Dohner H Estey E H Amadori S | 2010 | Blood2010，115，3： | 1 |
| 3 | Fludarabine potentiates me- tabolism of cytarabine in patients with acute myelogenous leukemia during therapy 显示文摘 | Gandhi V Estey E Keating M J | 2009 | J Clin Oncol2009，11，： | 1 |
| 4 | Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy显示文摘 | Gandhi V Estey E Keating MJ | 1993 | J Clin Oncol1993，11，1： | 1 |
| 5 | Use of Arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia显示文摘 | Lazo G Kantarjian H Estey E | 2003 | Cancer2003，97，9： | 1 |
| 6 | Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte- colony- stimulating factor during therapy of acute myelogenous leukemia显示文摘 | Gandhi V Estey E Du M | 1995 | Clin Cancer Res1995，1，2： | 1 |
| 7 | Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia显示文摘 | Aguayo A Estey E Kantarjian H | 1999 | Blood1999，94，11： | 1 |
| 8 | Com-parison of idarubicin+ara-C,fludarabine+ara-C,andtopotecan+ara-C-based regimens in treatment ofnewly diagnosed acute myeloid leukemia,refractory a-nemia with excess blasts in transformation,or refrac-tory anemia with excess blasts显示文摘 | ESTEY E H THALL P F CORTES J E | 2001 | Blood2001，98，： | 1 |
| 9 | Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myaloid leukemia 显示文摘 | Aguayo A Estey E Kantarjian H | 1999 | Blood1999，94，11： | 1 |
| 10 | Treatment of newly diagnosed AML and MDS with cyclophosphamide,ara-C and topotecan 显示文摘 | Estey E Kantarjian H Giles F | 1998 | Blood1998，，： | 1 |
| 11 | Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia显示文摘 | Gandhi V Estey E Du M | 1995 | Clin Cancer Res1995，1，2： | 1 |
| 12 | Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts intransformatio, or acute myeloid leukemia ) on outcome of AML-type chemotherapy显示文摘 | Estey E H Thall P Beran M | 1997 | Blood1997，90，8： | 1 |
| 13 | Cellular vascular growth factor is a predictor of outcome in patient with acute myeloid leukemia显示文摘 | Aguayo A Estey E Kantarjian H | 1999 | Blood1999，94，11： | 1 |
| 14 | Treatment of refractory AML 显示文摘 | Estey E | 1996 | Leukemia1996，10，： | 1 |
| 15 | Effective treatment of acute promy-elocytic leukemia with all-trans retinoic acid,arsenic trioxide,and gemtuzumab ozogamicin显示文摘 | Ravandi F Estey E Jones D | | 0，，： | 1 |
| 16 | Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia显示文摘 | Estey E Garcia-Manero G Ferrajoli A | 2006 | Blood2006，107，34： | 1 |
| 17 | Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome 显示文摘 | Meyers CA Albitar M Estey E | 2005 | Cancer2005，104，4： | 1 |
| 18 | Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA显示文摘 | ESTEY E MANSHURI T | 2003 | Leukemia2003，17，1： | 1 |
| 19 | Results of topotecan single-agent therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia 显示文摘 | Beran M Estey E O'Brien SM | 1998 | Leuk Lymphoma1998，31，3： | 1 |
| 20 | Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin 显示文摘 | Ravandi F Estey E Jones D | 2009 | J Clin Oncol2009，27，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员